Skip to content
Sign up to receive our free weekday morning edition, and you'll never miss a scoop.
The Canvass: Harris is more appealing than Biden to swing voters

Harris is more appealing than Biden to swing voters

Days after one of the most dramatic events in U.S. politics, nearly all top congressional aides and K Street leaders say President Joe Biden’s decision to suspend his reelection bid will help the Democratic Party’s chances of winning in November. That surprisingly includes 85% of Republicans who took the survey.

Just 5% of respondents to a special edition of our survey, The Canvass, conducted Tuesday with independent public affairs firm LSG, said Biden’s decision would hurt Democrats.

Vice President Kamala Harris’ likely nomination has energized women and Democratic voters as the party raised gobs of money in the immediate hours and days after Biden endorsed her. About 60% of respondents to our survey said Harris appeals more to swing voters than Biden.

The VP’s VP: Harris has a big decision to make: Who will be her vice president nominee? The Canvass respondents (54%) picked Pennsylvania Gov. Josh Shapiro as the most likely candidate followed by Arizona Sen. Mark Kelly (53%). A decision could come quickly as Democrats prepare for their convention in Chicago in less than a month.

Despite the more promising results for Harris and Democrats, The Canvass respondents still think Republican presidential nominee Donald Trump could win the election. Forty-seven percent said Trump would win, compared with 37% who picked Harris.

Interestingly, when The Canvass polled the same group of people last week on the final night of the Republican National Convention — while Biden was still the presumptive Democratic nominee — 71% said Trump would win then.

You can find the full results of The Canvass special edition rapid poll here.

Join The Canvass community: Our survey provides anonymous monthly insights from top Capitol Hill staffers and K Street leaders on key issues Washington is dealing with. Sign up here if you work on K Street. Click here to sign up if you’re a senior congressional staffer.

Presented by AstraZeneca

The 340B program was created to help patients. Instead, it’s helping hospitals earn massive profits. The 340B Rebate Model Pilot uses rapid verification of existing data to prevent duplicate discounts, strengthening program transparency and efficiency. Urge HHS to implement the Rebate Model Pilot and ensure 340B functions as intended. Get the facts.

Editorial photos provided by Getty Images. Political ads courtesy of AdImpact.

Presented by AstraZeneca

The 340B program is supposed to help vulnerable patients—but without strong safeguards, it’s siphoning away funds that could be used for free and charitable medicine. The 340B Rebate Model Pilot improves program integrity, preventing duplicate discounts and strengthening accountability. Urge HHS to implement the pilot today. Learn why it matters.

Welcome to Punchbowl News AM! We're glad to have you here.

Want to get more of what you need? Share a bit more about yourself to help us tailor your reader experience.

Thank you for signing up!

Thank you for signing up!

 

We have sent you a confirmation email. Please follow the provided instructions to complete your sign-up.

Thank you for confirming! You are now subscribed to the Punchbowl News AM list.

You're subscribed! Welcome to the community.